Pages that link to "Q46747403"

The following pages link to Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial (Q46747403):

Displaying 43 items.

• The gut hormones in appetite regulation (Q21296779) (← links)
• New advances in the treatment of generalized lipodystrophy: role of metreleptin (Q26781946) (← links)
• Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals (Q26859118) (← links)
• Metabolic shifts during aging and pathology (Q28088313) (← links)
• Gut-Brain Cross-Talk in Metabolic Control (Q30235568) (← links)
• The importance of gene-environment interactions in human obesity. (Q30248560) (← links)
• Tackling obesity: new therapeutic agents for assisted weight loss (Q30401145) (← links)
• Brain imaging studies of appetite in the context of obesity and the menstrual cycle (Q33516301) (← links)
• Nonalcoholic fatty liver disease: Diagnostic biomarkers. (Q33706254) (← links)
• Rhythmic leptin is required for weight gain from circadian desynchronized feeding in the mouse (Q34031939) (← links)
• Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms (Q35186358) (← links)
• Repositioning leptin as a therapy for Alzheimer’s disease (Q35569809) (← links)
• 20 years of leptin: role of leptin in energy homeostasis in humans (Q35679798) (← links)
• Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes (Q35762651) (← links)
• Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes (Q35796963) (← links)
• Leptin: at the crossroads of energy balance and systemic inflammation (Q35990442) (← links)
• Physiology of Weight Loss Surgery (Q36055375) (← links)
• The effects of long-term whole-body vibration and aerobic exercise on body composition and bone mineral density in obese middle-aged women (Q36099961) (← links)
• Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio (Q36711762) (← links)
• Higher maternal leptin levels at second trimester are associated with subsequent greater gestational weight gain in late pregnancy (Q36714981) (← links)
• Type 2 diabetes and cardiovascular disease: getting to the fat of the matter (Q36814772) (← links)
• Onset of leptin resistance shows temporal differences related to dose or pulsed treatment (Q36815153) (← links)
• Selective leptin resistance revisited (Q37147129) (← links)
• Reprogramming the body weight set point by a reciprocal interaction of hypothalamic leptin sensitivity and Pomc gene expression reverts extreme obesity (Q37278847) (← links)
• Diabetes mellitus, inflammation, obesity: proposed treatment pathways for current and future therapies (Q37710228) (← links)
• Leptin Receptors (Q37976352) (← links)
• New molecular targets in the pathophysiology of obesity and available treatment options under investigation (Q38397535) (← links)
• Proof‐of‐concept trial on the efficacy of sodium tungstate in human obesity (Q38499372) (← links)
• Intranasal delivery of mouse [D‐Leu‐4]‐OB3, a synthetic peptide amide with leptin‐like activity, improves energy balance, glycaemic control, insulin sensitivity and bone formation in leptin‐resistant C57BLK/6‐m db/db mice (Q42870610) (← links)
• Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study (Q43255700) (← links)
• The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women (Q46404895) (← links)
• The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss (Q47234580) (← links)
• Central Modulation of Energy Homeostasis and Cognitive Performance After Bariatric Surgery (Q48103365) (← links)
• Appetite-Related Gut Peptides in Obesity and Binge Eating Disorder (Q49147173) (← links)
• Role of hormonal and inflammatory alterations in obesity-related reproductive dysfunction at the level of the hypothalamic-pituitary-ovarian axis. (Q55313456) (← links)
• Oxytocin Administration Alleviates Acute but Not Chronic Leptin Resistance of Diet-Induced Obese Mice (Q60933260) (← links)
• Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy (Q88556380) (← links)
• Incendiary Leptin (Q89761521) (← links)
• Obesity, kidney dysfunction and hypertension: mechanistic links (Q90253318) (← links)
• Circulating leptin levels are associated with adiposity in survivors of childhood brain tumors (Q90316983) (← links)
• Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery (Q90612363) (← links)
• Administration of small-molecule guanabenz acetate attenuates fatty liver and hyperglycemia associated with obesity (Q98463608) (← links)
• Leptin alters energy intake and fat mass but not energy expenditure in lean subjects (Q100533662) (← links)